Berenberg Initiates Coverage On Twist Bioscience with Buy Rating, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
Berenberg analyst Gaurav Goparaju has initiated coverage on Twist Bioscience (NASDAQ:TWST) with a Buy rating and a price target of $27.
September 27, 2023 | 10:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Berenberg has initiated coverage on Twist Bioscience with a Buy rating and a price target of $27.
The Buy rating and price target set by Berenberg indicates a positive outlook for Twist Bioscience. This could potentially attract investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100